Global Factor Xa Inhibitors Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 155
Published Date: 16 Oct 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
Factor Xa inhibitors are anticoagulant drugs that block factor Xa, an enzyme crucial in the blood clotting process, thereby preventing clot formation. They are used to treat and prevent conditions like deep vein thrombosis, pulmonary embolism, and atrial fibrillation.
According to our (Global Info Research) latest study, the global Factor Xa Inhibitors market size was valued at US$ 22690 million in 2023 and is forecast to a readjusted size of USD 33430 million by 2030 with a CAGR of 5.7% during review period.
The market for Factor Xa inhibitors has been expanding steadily due to their advantages over traditional anticoagulants. Drugs like rivaroxaban, apixaban, and edoxaban are increasingly preferred for their ease of use, predictable dosing, and minimal need for routine monitoring. This shift has been driven by the need for more convenient and effective treatments for conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF).
Competition in the Factor Xa inhibitors market is growing as pharmaceutical companies continue to develop and launch new products with improved formulations. Efforts are focused on expanding the indications of these drugs, optimizing dosing regimens, and enhancing patient adherence. This competitive landscape is fostering innovation and leading to a wider range of options available to healthcare providers and patients.
However, the market faces challenges including high drug costs and the introduction of alternative therapies. Regulatory scrutiny and evolving treatment guidelines also impact market dynamics. Despite these challenges, ongoing advancements and research are expected to drive continued growth and development in the Factor Xa inhibitors market.
This report is a detailed and comprehensive analysis for global Factor Xa Inhibitors market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Factor Xa Inhibitors market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Factor Xa Inhibitors market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Factor Xa Inhibitors market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Factor Xa Inhibitors market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Factor Xa Inhibitors
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Factor Xa Inhibitors market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Bristol Myers Squibb, Daiichi Sankyo, Janssen Pharmaceuticals, Bayer, Viatris, Dr. Reddy's Laboratories, GlaxoSmithKline, Eugia Pharma, Accord Healthcare, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Factor Xa Inhibitors market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral Drugs
Injections
Market segment by Application
Deep Vein Thrombosis
Pulmonary Embolism
Atrial Fibrillation
Other
Major players covered
Pfizer
Bristol Myers Squibb
Daiichi Sankyo
Janssen Pharmaceuticals
Bayer
Viatris
Dr. Reddy's Laboratories
GlaxoSmithKline
Eugia Pharma
Accord Healthcare
Apotex
Zydus
Lupin
Jiangsu Hengrui Pharmaceuticals
Cspc Ouyi Pharmaceutical
Zhejiang Hisun Pharmaceutical
Hansoh Pharma
Chia Tai Tianqing Pharmaceutical
Shanghai Huilun Pharmaceutical
Qilu Pharmaceutical
HEC Pharma
BrightGene
Kelun Pharmaceutical
Nanjing King-Friend Biochemical Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Factor Xa Inhibitors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Factor Xa Inhibitors, with price, sales quantity, revenue, and global market share of Factor Xa Inhibitors from 2019 to 2024.
Chapter 3, the Factor Xa Inhibitors competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Factor Xa Inhibitors breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Factor Xa Inhibitors market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Factor Xa Inhibitors.
Chapter 14 and 15, to describe Factor Xa Inhibitors sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Factor Xa Inhibitors Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Oral Drugs
1.3.3 Injections
1.4 Market Analysis by Application
1.4.1 Overview: Global Factor Xa Inhibitors Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Deep Vein Thrombosis
1.4.3 Pulmonary Embolism
1.4.4 Atrial Fibrillation
1.4.5 Other
1.5 Global Factor Xa Inhibitors Market Size & Forecast
1.5.1 Global Factor Xa Inhibitors Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Factor Xa Inhibitors Sales Quantity (2019-2030)
1.5.3 Global Factor Xa Inhibitors Average Price (2019-2030)
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Factor Xa Inhibitors Product and Services
2.1.4 Pfizer Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Pfizer Recent Developments/Updates
2.2 Bristol Myers Squibb
2.2.1 Bristol Myers Squibb Details
2.2.2 Bristol Myers Squibb Major Business
2.2.3 Bristol Myers Squibb Factor Xa Inhibitors Product and Services
2.2.4 Bristol Myers Squibb Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Bristol Myers Squibb Recent Developments/Updates
2.3 Daiichi Sankyo
2.3.1 Daiichi Sankyo Details
2.3.2 Daiichi Sankyo Major Business
2.3.3 Daiichi Sankyo Factor Xa Inhibitors Product and Services
2.3.4 Daiichi Sankyo Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Daiichi Sankyo Recent Developments/Updates
2.4 Janssen Pharmaceuticals
2.4.1 Janssen Pharmaceuticals Details
2.4.2 Janssen Pharmaceuticals Major Business
2.4.3 Janssen Pharmaceuticals Factor Xa Inhibitors Product and Services
2.4.4 Janssen Pharmaceuticals Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Janssen Pharmaceuticals Recent Developments/Updates
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Factor Xa Inhibitors Product and Services
2.5.4 Bayer Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bayer Recent Developments/Updates
2.6 Viatris
2.6.1 Viatris Details
2.6.2 Viatris Major Business
2.6.3 Viatris Factor Xa Inhibitors Product and Services
2.6.4 Viatris Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Viatris Recent Developments/Updates
2.7 Dr. Reddy's Laboratories
2.7.1 Dr. Reddy's Laboratories Details
2.7.2 Dr. Reddy's Laboratories Major Business
2.7.3 Dr. Reddy's Laboratories Factor Xa Inhibitors Product and Services
2.7.4 Dr. Reddy's Laboratories Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Dr. Reddy's Laboratories Recent Developments/Updates
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Factor Xa Inhibitors Product and Services
2.8.4 GlaxoSmithKline Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GlaxoSmithKline Recent Developments/Updates
2.9 Eugia Pharma
2.9.1 Eugia Pharma Details
2.9.2 Eugia Pharma Major Business
2.9.3 Eugia Pharma Factor Xa Inhibitors Product and Services
2.9.4 Eugia Pharma Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eugia Pharma Recent Developments/Updates
2.10 Accord Healthcare
2.10.1 Accord Healthcare Details
2.10.2 Accord Healthcare Major Business
2.10.3 Accord Healthcare Factor Xa Inhibitors Product and Services
2.10.4 Accord Healthcare Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Accord Healthcare Recent Developments/Updates
2.11 Apotex
2.11.1 Apotex Details
2.11.2 Apotex Major Business
2.11.3 Apotex Factor Xa Inhibitors Product and Services
2.11.4 Apotex Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Apotex Recent Developments/Updates
2.12 Zydus
2.12.1 Zydus Details
2.12.2 Zydus Major Business
2.12.3 Zydus Factor Xa Inhibitors Product and Services
2.12.4 Zydus Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Zydus Recent Developments/Updates
2.13 Lupin
2.13.1 Lupin Details
2.13.2 Lupin Major Business
2.13.3 Lupin Factor Xa Inhibitors Product and Services
2.13.4 Lupin Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Lupin Recent Developments/Updates
2.14 Jiangsu Hengrui Pharmaceuticals
2.14.1 Jiangsu Hengrui Pharmaceuticals Details
2.14.2 Jiangsu Hengrui Pharmaceuticals Major Business
2.14.3 Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Product and Services
2.14.4 Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
2.15 Cspc Ouyi Pharmaceutical
2.15.1 Cspc Ouyi Pharmaceutical Details
2.15.2 Cspc Ouyi Pharmaceutical Major Business
2.15.3 Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Product and Services
2.15.4 Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Cspc Ouyi Pharmaceutical Recent Developments/Updates
2.16 Zhejiang Hisun Pharmaceutical
2.16.1 Zhejiang Hisun Pharmaceutical Details
2.16.2 Zhejiang Hisun Pharmaceutical Major Business
2.16.3 Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Product and Services
2.16.4 Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
2.17 Hansoh Pharma
2.17.1 Hansoh Pharma Details
2.17.2 Hansoh Pharma Major Business
2.17.3 Hansoh Pharma Factor Xa Inhibitors Product and Services
2.17.4 Hansoh Pharma Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Hansoh Pharma Recent Developments/Updates
2.18 Chia Tai Tianqing Pharmaceutical
2.18.1 Chia Tai Tianqing Pharmaceutical Details
2.18.2 Chia Tai Tianqing Pharmaceutical Major Business
2.18.3 Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Product and Services
2.18.4 Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
2.19 Shanghai Huilun Pharmaceutical
2.19.1 Shanghai Huilun Pharmaceutical Details
2.19.2 Shanghai Huilun Pharmaceutical Major Business
2.19.3 Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Product and Services
2.19.4 Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanghai Huilun Pharmaceutical Recent Developments/Updates
2.20 Qilu Pharmaceutical
2.20.1 Qilu Pharmaceutical Details
2.20.2 Qilu Pharmaceutical Major Business
2.20.3 Qilu Pharmaceutical Factor Xa Inhibitors Product and Services
2.20.4 Qilu Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Qilu Pharmaceutical Recent Developments/Updates
2.21 HEC Pharma
2.21.1 HEC Pharma Details
2.21.2 HEC Pharma Major Business
2.21.3 HEC Pharma Factor Xa Inhibitors Product and Services
2.21.4 HEC Pharma Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 HEC Pharma Recent Developments/Updates
2.22 BrightGene
2.22.1 BrightGene Details
2.22.2 BrightGene Major Business
2.22.3 BrightGene Factor Xa Inhibitors Product and Services
2.22.4 BrightGene Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 BrightGene Recent Developments/Updates
2.23 Kelun Pharmaceutical
2.23.1 Kelun Pharmaceutical Details
2.23.2 Kelun Pharmaceutical Major Business
2.23.3 Kelun Pharmaceutical Factor Xa Inhibitors Product and Services
2.23.4 Kelun Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Kelun Pharmaceutical Recent Developments/Updates
2.24 Nanjing King-Friend Biochemical Pharmaceutical
2.24.1 Nanjing King-Friend Biochemical Pharmaceutical Details
2.24.2 Nanjing King-Friend Biochemical Pharmaceutical Major Business
2.24.3 Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Product and Services
2.24.4 Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Nanjing King-Friend Biochemical Pharmaceutical Recent Developments/Updates
3.1 Global Factor Xa Inhibitors Sales Quantity by Manufacturer (2019-2024)
3.2 Global Factor Xa Inhibitors Revenue by Manufacturer (2019-2024)
3.3 Global Factor Xa Inhibitors Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Factor Xa Inhibitors by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Factor Xa Inhibitors Manufacturer Market Share in 2023
3.4.3 Top 6 Factor Xa Inhibitors Manufacturer Market Share in 2023
3.5 Factor Xa Inhibitors Market: Overall Company Footprint Analysis
3.5.1 Factor Xa Inhibitors Market: Region Footprint
3.5.2 Factor Xa Inhibitors Market: Company Product Type Footprint
3.5.3 Factor Xa Inhibitors Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Factor Xa Inhibitors Market Size by Region
4.1.1 Global Factor Xa Inhibitors Sales Quantity by Region (2019-2030)
4.1.2 Global Factor Xa Inhibitors Consumption Value by Region (2019-2030)
4.1.3 Global Factor Xa Inhibitors Average Price by Region (2019-2030)
4.2 North America Factor Xa Inhibitors Consumption Value (2019-2030)
4.3 Europe Factor Xa Inhibitors Consumption Value (2019-2030)
4.4 Asia-Pacific Factor Xa Inhibitors Consumption Value (2019-2030)
4.5 South America Factor Xa Inhibitors Consumption Value (2019-2030)
4.6 Middle East & Africa Factor Xa Inhibitors Consumption Value (2019-2030)
5.1 Global Factor Xa Inhibitors Sales Quantity by Type (2019-2030)
5.2 Global Factor Xa Inhibitors Consumption Value by Type (2019-2030)
5.3 Global Factor Xa Inhibitors Average Price by Type (2019-2030)
6.1 Global Factor Xa Inhibitors Sales Quantity by Application (2019-2030)
6.2 Global Factor Xa Inhibitors Consumption Value by Application (2019-2030)
6.3 Global Factor Xa Inhibitors Average Price by Application (2019-2030)
7.1 North America Factor Xa Inhibitors Sales Quantity by Type (2019-2030)
7.2 North America Factor Xa Inhibitors Sales Quantity by Application (2019-2030)
7.3 North America Factor Xa Inhibitors Market Size by Country
7.3.1 North America Factor Xa Inhibitors Sales Quantity by Country (2019-2030)
7.3.2 North America Factor Xa Inhibitors Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Factor Xa Inhibitors Sales Quantity by Type (2019-2030)
8.2 Europe Factor Xa Inhibitors Sales Quantity by Application (2019-2030)
8.3 Europe Factor Xa Inhibitors Market Size by Country
8.3.1 Europe Factor Xa Inhibitors Sales Quantity by Country (2019-2030)
8.3.2 Europe Factor Xa Inhibitors Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Factor Xa Inhibitors Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Factor Xa Inhibitors Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Factor Xa Inhibitors Market Size by Region
9.3.1 Asia-Pacific Factor Xa Inhibitors Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Factor Xa Inhibitors Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Factor Xa Inhibitors Sales Quantity by Type (2019-2030)
10.2 South America Factor Xa Inhibitors Sales Quantity by Application (2019-2030)
10.3 South America Factor Xa Inhibitors Market Size by Country
10.3.1 South America Factor Xa Inhibitors Sales Quantity by Country (2019-2030)
10.3.2 South America Factor Xa Inhibitors Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Factor Xa Inhibitors Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Factor Xa Inhibitors Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Factor Xa Inhibitors Market Size by Country
11.3.1 Middle East & Africa Factor Xa Inhibitors Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Factor Xa Inhibitors Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Factor Xa Inhibitors Market Drivers
12.2 Factor Xa Inhibitors Market Restraints
12.3 Factor Xa Inhibitors Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Factor Xa Inhibitors and Key Manufacturers
13.2 Manufacturing Costs Percentage of Factor Xa Inhibitors
13.3 Factor Xa Inhibitors Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Factor Xa Inhibitors Typical Distributors
14.3 Factor Xa Inhibitors Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Factor Xa Inhibitors Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Factor Xa Inhibitors Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Factor Xa Inhibitors Product and Services
Table 6. Pfizer Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Pfizer Recent Developments/Updates
Table 8. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 9. Bristol Myers Squibb Major Business
Table 10. Bristol Myers Squibb Factor Xa Inhibitors Product and Services
Table 11. Bristol Myers Squibb Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Bristol Myers Squibb Recent Developments/Updates
Table 13. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 14. Daiichi Sankyo Major Business
Table 15. Daiichi Sankyo Factor Xa Inhibitors Product and Services
Table 16. Daiichi Sankyo Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Daiichi Sankyo Recent Developments/Updates
Table 18. Janssen Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Janssen Pharmaceuticals Major Business
Table 20. Janssen Pharmaceuticals Factor Xa Inhibitors Product and Services
Table 21. Janssen Pharmaceuticals Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Janssen Pharmaceuticals Recent Developments/Updates
Table 23. Bayer Basic Information, Manufacturing Base and Competitors
Table 24. Bayer Major Business
Table 25. Bayer Factor Xa Inhibitors Product and Services
Table 26. Bayer Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Bayer Recent Developments/Updates
Table 28. Viatris Basic Information, Manufacturing Base and Competitors
Table 29. Viatris Major Business
Table 30. Viatris Factor Xa Inhibitors Product and Services
Table 31. Viatris Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Viatris Recent Developments/Updates
Table 33. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 34. Dr. Reddy's Laboratories Major Business
Table 35. Dr. Reddy's Laboratories Factor Xa Inhibitors Product and Services
Table 36. Dr. Reddy's Laboratories Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Dr. Reddy's Laboratories Recent Developments/Updates
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Major Business
Table 40. GlaxoSmithKline Factor Xa Inhibitors Product and Services
Table 41. GlaxoSmithKline Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GlaxoSmithKline Recent Developments/Updates
Table 43. Eugia Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Eugia Pharma Major Business
Table 45. Eugia Pharma Factor Xa Inhibitors Product and Services
Table 46. Eugia Pharma Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Eugia Pharma Recent Developments/Updates
Table 48. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 49. Accord Healthcare Major Business
Table 50. Accord Healthcare Factor Xa Inhibitors Product and Services
Table 51. Accord Healthcare Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Accord Healthcare Recent Developments/Updates
Table 53. Apotex Basic Information, Manufacturing Base and Competitors
Table 54. Apotex Major Business
Table 55. Apotex Factor Xa Inhibitors Product and Services
Table 56. Apotex Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Apotex Recent Developments/Updates
Table 58. Zydus Basic Information, Manufacturing Base and Competitors
Table 59. Zydus Major Business
Table 60. Zydus Factor Xa Inhibitors Product and Services
Table 61. Zydus Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Zydus Recent Developments/Updates
Table 63. Lupin Basic Information, Manufacturing Base and Competitors
Table 64. Lupin Major Business
Table 65. Lupin Factor Xa Inhibitors Product and Services
Table 66. Lupin Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Lupin Recent Developments/Updates
Table 68. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 69. Jiangsu Hengrui Pharmaceuticals Major Business
Table 70. Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Product and Services
Table 71. Jiangsu Hengrui Pharmaceuticals Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 73. Cspc Ouyi Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Cspc Ouyi Pharmaceutical Major Business
Table 75. Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Product and Services
Table 76. Cspc Ouyi Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Cspc Ouyi Pharmaceutical Recent Developments/Updates
Table 78. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 79. Zhejiang Hisun Pharmaceutical Major Business
Table 80. Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Product and Services
Table 81. Zhejiang Hisun Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 83. Hansoh Pharma Basic Information, Manufacturing Base and Competitors
Table 84. Hansoh Pharma Major Business
Table 85. Hansoh Pharma Factor Xa Inhibitors Product and Services
Table 86. Hansoh Pharma Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Hansoh Pharma Recent Developments/Updates
Table 88. Chia Tai Tianqing Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Chia Tai Tianqing Pharmaceutical Major Business
Table 90. Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Product and Services
Table 91. Chia Tai Tianqing Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 93. Shanghai Huilun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 94. Shanghai Huilun Pharmaceutical Major Business
Table 95. Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Product and Services
Table 96. Shanghai Huilun Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Shanghai Huilun Pharmaceutical Recent Developments/Updates
Table 98. Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 99. Qilu Pharmaceutical Major Business
Table 100. Qilu Pharmaceutical Factor Xa Inhibitors Product and Services
Table 101. Qilu Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Qilu Pharmaceutical Recent Developments/Updates
Table 103. HEC Pharma Basic Information, Manufacturing Base and Competitors
Table 104. HEC Pharma Major Business
Table 105. HEC Pharma Factor Xa Inhibitors Product and Services
Table 106. HEC Pharma Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. HEC Pharma Recent Developments/Updates
Table 108. BrightGene Basic Information, Manufacturing Base and Competitors
Table 109. BrightGene Major Business
Table 110. BrightGene Factor Xa Inhibitors Product and Services
Table 111. BrightGene Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. BrightGene Recent Developments/Updates
Table 113. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 114. Kelun Pharmaceutical Major Business
Table 115. Kelun Pharmaceutical Factor Xa Inhibitors Product and Services
Table 116. Kelun Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 117. Kelun Pharmaceutical Recent Developments/Updates
Table 118. Nanjing King-Friend Biochemical Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 119. Nanjing King-Friend Biochemical Pharmaceutical Major Business
Table 120. Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Product and Services
Table 121. Nanjing King-Friend Biochemical Pharmaceutical Factor Xa Inhibitors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 122. Nanjing King-Friend Biochemical Pharmaceutical Recent Developments/Updates
Table 123. Global Factor Xa Inhibitors Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 124. Global Factor Xa Inhibitors Revenue by Manufacturer (2019-2024) & (USD Million)
Table 125. Global Factor Xa Inhibitors Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 126. Market Position of Manufacturers in Factor Xa Inhibitors, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 127. Head Office and Factor Xa Inhibitors Production Site of Key Manufacturer
Table 128. Factor Xa Inhibitors Market: Company Product Type Footprint
Table 129. Factor Xa Inhibitors Market: Company Product Application Footprint
Table 130. Factor Xa Inhibitors New Market Entrants and Barriers to Market Entry
Table 131. Factor Xa Inhibitors Mergers, Acquisition, Agreements, and Collaborations
Table 132. Global Factor Xa Inhibitors Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 133. Global Factor Xa Inhibitors Sales Quantity by Region (2019-2024) & (K Units)
Table 134. Global Factor Xa Inhibitors Sales Quantity by Region (2025-2030) & (K Units)
Table 135. Global Factor Xa Inhibitors Consumption Value by Region (2019-2024) & (USD Million)
Table 136. Global Factor Xa Inhibitors Consumption Value by Region (2025-2030) & (USD Million)
Table 137. Global Factor Xa Inhibitors Average Price by Region (2019-2024) & (US$/Unit)
Table 138. Global Factor Xa Inhibitors Average Price by Region (2025-2030) & (US$/Unit)
Table 139. Global Factor Xa Inhibitors Sales Quantity by Type (2019-2024) & (K Units)
Table 140. Global Factor Xa Inhibitors Sales Quantity by Type (2025-2030) & (K Units)
Table 141. Global Factor Xa Inhibitors Consumption Value by Type (2019-2024) & (USD Million)
Table 142. Global Factor Xa Inhibitors Consumption Value by Type (2025-2030) & (USD Million)
Table 143. Global Factor Xa Inhibitors Average Price by Type (2019-2024) & (US$/Unit)
Table 144. Global Factor Xa Inhibitors Average Price by Type (2025-2030) & (US$/Unit)
Table 145. Global Factor Xa Inhibitors Sales Quantity by Application (2019-2024) & (K Units)
Table 146. Global Factor Xa Inhibitors Sales Quantity by Application (2025-2030) & (K Units)
Table 147. Global Factor Xa Inhibitors Consumption Value by Application (2019-2024) & (USD Million)
Table 148. Global Factor Xa Inhibitors Consumption Value by Application (2025-2030) & (USD Million)
Table 149. Global Factor Xa Inhibitors Average Price by Application (2019-2024) & (US$/Unit)
Table 150. Global Factor Xa Inhibitors Average Price by Application (2025-2030) & (US$/Unit)
Table 151. North America Factor Xa Inhibitors Sales Quantity by Type (2019-2024) & (K Units)
Table 152. North America Factor Xa Inhibitors Sales Quantity by Type (2025-2030) & (K Units)
Table 153. North America Factor Xa Inhibitors Sales Quantity by Application (2019-2024) & (K Units)
Table 154. North America Factor Xa Inhibitors Sales Quantity by Application (2025-2030) & (K Units)
Table 155. North America Factor Xa Inhibitors Sales Quantity by Country (2019-2024) & (K Units)
Table 156. North America Factor Xa Inhibitors Sales Quantity by Country (2025-2030) & (K Units)
Table 157. North America Factor Xa Inhibitors Consumption Value by Country (2019-2024) & (USD Million)
Table 158. North America Factor Xa Inhibitors Consumption Value by Country (2025-2030) & (USD Million)
Table 159. Europe Factor Xa Inhibitors Sales Quantity by Type (2019-2024) & (K Units)
Table 160. Europe Factor Xa Inhibitors Sales Quantity by Type (2025-2030) & (K Units)
Table 161. Europe Factor Xa Inhibitors Sales Quantity by Application (2019-2024) & (K Units)
Table 162. Europe Factor Xa Inhibitors Sales Quantity by Application (2025-2030) & (K Units)
Table 163. Europe Factor Xa Inhibitors Sales Quantity by Country (2019-2024) & (K Units)
Table 164. Europe Factor Xa Inhibitors Sales Quantity by Country (2025-2030) & (K Units)
Table 165. Europe Factor Xa Inhibitors Consumption Value by Country (2019-2024) & (USD Million)
Table 166. Europe Factor Xa Inhibitors Consumption Value by Country (2025-2030) & (USD Million)
Table 167. Asia-Pacific Factor Xa Inhibitors Sales Quantity by Type (2019-2024) & (K Units)
Table 168. Asia-Pacific Factor Xa Inhibitors Sales Quantity by Type (2025-2030) & (K Units)
Table 169. Asia-Pacific Factor Xa Inhibitors Sales Quantity by Application (2019-2024) & (K Units)
Table 170. Asia-Pacific Factor Xa Inhibitors Sales Quantity by Application (2025-2030) & (K Units)
Table 171. Asia-Pacific Factor Xa Inhibitors Sales Quantity by Region (2019-2024) & (K Units)
Table 172. Asia-Pacific Factor Xa Inhibitors Sales Quantity by Region (2025-2030) & (K Units)
Table 173. Asia-Pacific Factor Xa Inhibitors Consumption Value by Region (2019-2024) & (USD Million)
Table 174. Asia-Pacific Factor Xa Inhibitors Consumption Value by Region (2025-2030) & (USD Million)
Table 175. South America Factor Xa Inhibitors Sales Quantity by Type (2019-2024) & (K Units)
Table 176. South America Factor Xa Inhibitors Sales Quantity by Type (2025-2030) & (K Units)
Table 177. South America Factor Xa Inhibitors Sales Quantity by Application (2019-2024) & (K Units)
Table 178. South America Factor Xa Inhibitors Sales Quantity by Application (2025-2030) & (K Units)
Table 179. South America Factor Xa Inhibitors Sales Quantity by Country (2019-2024) & (K Units)
Table 180. South America Factor Xa Inhibitors Sales Quantity by Country (2025-2030) & (K Units)
Table 181. South America Factor Xa Inhibitors Consumption Value by Country (2019-2024) & (USD Million)
Table 182. South America Factor Xa Inhibitors Consumption Value by Country (2025-2030) & (USD Million)
Table 183. Middle East & Africa Factor Xa Inhibitors Sales Quantity by Type (2019-2024) & (K Units)
Table 184. Middle East & Africa Factor Xa Inhibitors Sales Quantity by Type (2025-2030) & (K Units)
Table 185. Middle East & Africa Factor Xa Inhibitors Sales Quantity by Application (2019-2024) & (K Units)
Table 186. Middle East & Africa Factor Xa Inhibitors Sales Quantity by Application (2025-2030) & (K Units)
Table 187. Middle East & Africa Factor Xa Inhibitors Sales Quantity by Country (2019-2024) & (K Units)
Table 188. Middle East & Africa Factor Xa Inhibitors Sales Quantity by Country (2025-2030) & (K Units)
Table 189. Middle East & Africa Factor Xa Inhibitors Consumption Value by Country (2019-2024) & (USD Million)
Table 190. Middle East & Africa Factor Xa Inhibitors Consumption Value by Country (2025-2030) & (USD Million)
Table 191. Factor Xa Inhibitors Raw Material
Table 192. Key Manufacturers of Factor Xa Inhibitors Raw Materials
Table 193. Factor Xa Inhibitors Typical Distributors
Table 194. Factor Xa Inhibitors Typical Customers
List of Figures
Figure 1. Factor Xa Inhibitors Picture
Figure 2. Global Factor Xa Inhibitors Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Factor Xa Inhibitors Revenue Market Share by Type in 2023
Figure 4. Oral Drugs Examples
Figure 5. Injections Examples
Figure 6. Global Factor Xa Inhibitors Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Factor Xa Inhibitors Revenue Market Share by Application in 2023
Figure 8. Deep Vein Thrombosis Examples
Figure 9. Pulmonary Embolism Examples
Figure 10. Atrial Fibrillation Examples
Figure 11. Other Examples
Figure 12. Global Factor Xa Inhibitors Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Factor Xa Inhibitors Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Factor Xa Inhibitors Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Factor Xa Inhibitors Price (2019-2030) & (US$/Unit)
Figure 16. Global Factor Xa Inhibitors Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Factor Xa Inhibitors Revenue Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Factor Xa Inhibitors by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 19. Top 3 Factor Xa Inhibitors Manufacturer (Revenue) Market Share in 2023
Figure 20. Top 6 Factor Xa Inhibitors Manufacturer (Revenue) Market Share in 2023
Figure 21. Global Factor Xa Inhibitors Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Factor Xa Inhibitors Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Factor Xa Inhibitors Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Factor Xa Inhibitors Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Factor Xa Inhibitors Average Price by Type (2019-2030) & (US$/Unit)
Figure 31. Global Factor Xa Inhibitors Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Factor Xa Inhibitors Revenue Market Share by Application (2019-2030)
Figure 33. Global Factor Xa Inhibitors Average Price by Application (2019-2030) & (US$/Unit)
Figure 34. North America Factor Xa Inhibitors Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Factor Xa Inhibitors Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Factor Xa Inhibitors Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Factor Xa Inhibitors Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Factor Xa Inhibitors Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Factor Xa Inhibitors Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Factor Xa Inhibitors Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Factor Xa Inhibitors Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 46. France Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 47. United Kingdom Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 48. Russia Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 49. Italy Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Factor Xa Inhibitors Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Factor Xa Inhibitors Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Factor Xa Inhibitors Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Factor Xa Inhibitors Consumption Value Market Share by Region (2019-2030)
Figure 54. China Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 55. Japan Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 56. South Korea Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 57. India Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 58. Southeast Asia Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 59. Australia Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 60. South America Factor Xa Inhibitors Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Factor Xa Inhibitors Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Factor Xa Inhibitors Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Factor Xa Inhibitors Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 65. Argentina Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Factor Xa Inhibitors Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Factor Xa Inhibitors Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Factor Xa Inhibitors Sales Quantity Market Share by Country (2019-2030)
Figure 69. Middle East & Africa Factor Xa Inhibitors Consumption Value Market Share by Country (2019-2030)
Figure 70. Turkey Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 71. Egypt Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 73. South Africa Factor Xa Inhibitors Consumption Value (2019-2030) & (USD Million)
Figure 74. Factor Xa Inhibitors Market Drivers
Figure 75. Factor Xa Inhibitors Market Restraints
Figure 76. Factor Xa Inhibitors Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Factor Xa Inhibitors in 2023
Figure 79. Manufacturing Process Analysis of Factor Xa Inhibitors
Figure 80. Factor Xa Inhibitors Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer Bristol Myers Squibb Daiichi Sankyo Janssen Pharmaceuticals Bayer Viatris Dr. Reddy's Laboratories GlaxoSmithKline Eugia Pharma Accord Healthcare Apotex Zydus Lupin Jiangsu Hengrui Pharmaceuticals Cspc Ouyi Pharmaceutical Zhejiang Hisun Pharmaceutical Hansoh Pharma Chia Tai Tianqing Pharmaceutical Shanghai Huilun Pharmaceutical Qilu Pharmaceutical HEC Pharma BrightGene Kelun Pharmaceutical Nanjing King-Friend Biochemical Pharmaceutical
16 Oct 2024
Pharma & Healthcare
Product Tags
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
